Note 2 - Equity Method Investment

3 Months Ended

Mar. 31, 2019

Notes to Financial Statements

Equity Method Investments and Joint Ventures Disclosure [Text Block]

NOTE

2

– EQUITY METHOD INVESTMENT

The Company has an equity method investment in Helomics. Summarized financial information for Helomics is presented below:

Helomics Holdings Corporation

	For the three Months Ended
	March 31, 2019
Revenue	$	45,835
Gross margin	$	7,348
Net loss from continuing operations	$	(1,555,542	)
Net loss to investee	$	(1,166,656	) 1

1

The loss to investee was calculated at

75%

for the

three

-month period representing the ownership percentage in Helomics owned by other parties.